We are live on
!
Find out more
Celldex Therapeutics
CLDX
CLDX
185 hedge funds and large institutions have $2B invested in Celldex Therapeutics in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 59 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
205% more call options, than puts
Call options by funds: $2.29M | Put options by funds: $750K
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
14% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 22
9% more capital invested
Capital invested by funds: $1.83B → $2B (+$169M)
3.7% more ownership
Funds ownership: 106.51% → 110.21% (+3.7%)
1% more funds holding
Funds holding: 184 → 185 (+1)
2% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 59
Holders
185
Holders Change
+1
Holders Change %
+0.54%
% of All Funds
2.25%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
25
Increased
58
Reduced
59
Closed
22
Calls
$2.29M
Puts
$750K
Net Calls
+$1.53M
Net Calls Change
+$4.97M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$60M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$33.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$14.6M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$14.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.4M |
